Buying Existing Drugs And Raising Prices Aggressively Squeezes Healthcare Providers, Insurers, And Patients

Valeant's Drug Price Strategy enriches It, But Infuriates Patients And Lawmakers by Andrew Pollack And Sabrina Tavernise.  The New York Times.  October 4, 2015.